NPI: 1770561094 · LOS ANGELES, CA 90015 · Clinical Medical Laboratory · NPI assigned 01/06/2006
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 01/06/2006 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,196 | $2K |
| 2019 | 1,604 | $3K |
| 2020 | 1,422 | $4K |
| 2021 | 862 | $412.18 |
| 2022 | 1,170 | $5K |
| 2023 | 1,755 | $6K |
| 2024 | 1,579 | $5K |
| Code | Description | Claims | Bene. Records | Total Paid |
|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 2,757 | 2,516 | $14K |
| 80053 | Comprehensive metabolic panel | 1,530 | 1,377 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,149 | 1,968 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 46 | 46 | $1K |
| 82247 | 213 | 165 | $756.23 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 14 | 14 | $491.50 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13 | 13 | $468.59 |
| 84443 | Thyroid stimulating hormone (TSH) | 23 | 23 | $336.03 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 13 | 13 | $282.75 |
| 80061 | Lipid panel | 24 | 24 | $274.08 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 12 | 12 | $243.12 |
| 83036 | Hemoglobin; glycosylated (A1C) | 22 | 22 | $185.90 |
| 85610 | 393 | 377 | $166.24 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 306 | 301 | $146.16 |
| 85730 | 209 | 207 | $144.49 | |
| 82248 | 72 | 62 | $140.95 | |
| 36415 | Collection of venous blood by venipuncture | 1,165 | 1,063 | $135.14 |
| 86592 | 17 | 17 | $58.74 | |
| 81001 | 13 | 13 | $24.75 | |
| 81003 | 15 | 15 | $17.46 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 258 | 219 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 324 | 277 | $0.00 |